Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Biohaven Ltd. | 68,693 | reported | 28 Apr 2026 | tx 17+343,001−38,423 |
| COLLEGIUM PHARMACEUTICAL, INC | 50,328 | reported | 10 Feb 2025 | tx 110+1,254,704−1,856,713 |
| Trevi Therapeutics, Inc. | 45,000 | reported | 11 Jun 2025 | tx 11+209,245−34,247 |
| enGene Holdings Inc. | 45,000 | reported | 08 Jul 2025 | tx 1+45,000 |
| Mirna Therapeutics, Inc. | 30,000 | reported | 22 Jun 2023 | tx 4+102,000 |
| Avalo Therapeutics, Inc. | 29,500 | reported | 17 Jun 2025 | tx 2+79,500 |
| Akebia Therapeutics, Inc. | 20,100 | reported | 02 Jun 2021 | tx 11+175,060 |
| KERYX BIOPHARMACEUTICALS INC | 0 | reported | 12 Dec 2018 | tx 7+130,000−130,000 |
| Biohaven Pharmaceutical Holding Co Ltd. | 0 | reported | 03 Oct 2022 | tx 11+103,755−49,755 |
| CRITICAL THERAPEUTICS INC | 0 | reported | 03 Feb 2014 | tx 14+79,404−79,404 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 Apr 2026 | GRANT_AWARD | Biohaven Ltd. | 68,693 | 0.00 USD | deriv |
| 08 Jul 2025 | GRANT_AWARD | enGene Holdings Inc. | 45,000 | 0.00 USD | deriv |
| 17 Jun 2025 | GRANT_AWARD | Avalo Therapeutics, Inc. | 29,500 | 0.00 USD | deriv |
| 11 Jun 2025 | GRANT_AWARD | Trevi Therapeutics, Inc. | 45,000 | 0.00 USD | deriv |
| 05 May 2025 | GRANT_AWARD | Biohaven Ltd. | 31,716 | 0.00 USD | deriv |
| 25 Mar 2025 | GRANT_AWARD | Avalo Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 10 Feb 2025 | GRANT_AWARD | COLLEGIUM PHARMACEUTICAL, INC | 4,820 | 0.00 USD | |
| 13 Jun 2024 | GRANT_AWARD | Trevi Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 16 May 2024 | GRANT_AWARD | COLLEGIUM PHARMACEUTICAL, INC | 7,693 | 0.00 USD | |
| 30 Apr 2024 | GRANT_AWARD | Biohaven Ltd. | 16,592 | 0.00 USD | deriv |
| 28 Jun 2023 | GRANT_AWARD | Trevi Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 22 Jun 2023 | GRANT_AWARD | Mirna Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 18 May 2023 | GRANT_AWARD | COLLEGIUM PHARMACEUTICAL, INC | 9,792 | 0.00 USD | |
| 02 May 2023 | GRANT_AWARD | Biohaven Ltd. | 52,906 | 0.00 USD | deriv |
| 27 Dec 2022 | SALE | COLLEGIUM PHARMACEUTICAL, INC | 15,995 | 23.63 USD | |
| 27 Dec 2022 | EXERCISE | COLLEGIUM PHARMACEUTICAL, INC | 15,995 | 16.15 USD | |
| 27 Dec 2022 | EXERCISE | COLLEGIUM PHARMACEUTICAL, INC | 3,820 | 16.15 USD | |
| 23 Dec 2022 | EXERCISE | COLLEGIUM PHARMACEUTICAL, INC | 4,989 | 16.15 USD | |
| 22 Dec 2022 | SALE | COLLEGIUM PHARMACEUTICAL, INC | 237 | 23.00 USD | |
| 22 Dec 2022 | EXERCISE | COLLEGIUM PHARMACEUTICAL, INC | 237 | 16.15 USD | |
| 23 Dec 2022 | SALE | COLLEGIUM PHARMACEUTICAL, INC | 4,989 | 23.00 USD | |
| 27 Dec 2022 | SALE | COLLEGIUM PHARMACEUTICAL, INC | 3,820 | 24.16 USD | |
| 27 Dec 2022 | EXERCISE | COLLEGIUM PHARMACEUTICAL, INC | 3,820 | 0.00 USD | deriv |
| 27 Dec 2022 | EXERCISE | COLLEGIUM PHARMACEUTICAL, INC | 15,995 | 0.00 USD | deriv |
| 23 Dec 2022 | EXERCISE | COLLEGIUM PHARMACEUTICAL, INC | 4,989 | 0.00 USD | deriv |